Considering that tumor progression was mainly affected by tumor proliferation, invasion, metastasis, and the amount of angiogenesis, the Nrf2 inhibition by CPT may provide a novel exploration about invasion, metastasis, and angiogenesis in HCC treatment. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.